<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37358634</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>270</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Autonomic dysfunction is associated with disease progression and survival in amyotrophic lateral sclerosis: a prospective longitudinal cohort study.</ArticleTitle><Pagination><StartPage>4968</StartPage><EndPage>4977</EndPage><MedlinePgn>4968-4977</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-023-11832-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Among non-motor symptoms, autonomic disturbances have been described in amyotrophic lateral sclerosis (ALS) and reported as mild to moderate in up to 75% of patients. However, no study has systematically investigated autonomic symptoms as prognostic factors.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The main aim of this longitudinal study was to examine the association of autonomic dysfunction with disease progression and survival in ALS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled newly diagnosed ALS patients and a healthy control group (HC). Time from disease onset to disease milestone (King's stage 4) and death were calculated to assess disease progression and survival. Autonomic symptoms were assessed by a dedicated questionnaire. Longitudinal evaluation of parasympathetic cardiovascular activity was performed by the heart rate variability (HRV). Multivariable Cox proportional hazards regression models on the risk of the disease milestone and death were used. A mixed-effect linear regression model was used to compare autonomic dysfunction with a HC group as well as its impairment over time.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 102 patients and 41 HC were studied. ALS patients, compared with HC, complained of more autonomic symptoms, especially in bulbar onset patients. Autonomic symptoms occurred in 69 (68%) patients at diagnosis and progressed over time (post-6: p&#x2009;=&#x2009;0.015 and post-12: p&#x2009;&lt;&#x2009;0.001). A higher autonomic symptom burden was an independent marker of faster development of King's stage 4 (HR 1.05; 95% CI 1.00-1.11; p&#x2009;=&#x2009;0.022); whereas, urinary complaints were independent factors of a shorter survival (HR 3.12; 95% CI 1.22-7.97; p&#x2009;=&#x2009;0.018). Moreover, HRV in ALS patients was lower than in HC (p&#x2009;=&#x2009;0.018) and further decreased over time (p&#x2009;=&#x2009;0.003), implying a parasympathetic hypofunction that progressed over time.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Autonomic symptoms occur in most of the ALS patients at diagnosis and progress over time, implying that autonomic dysfunction represents an intrinsic non-motor feature of the disease. A higher autonomic burden is a poor prognostic factor, associated with a more rapid development of disease milestones and shorter survival.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dubbioso</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2487-4741</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II of Naples, Via Sergio Pansini, 5, 80131, Naples, Italy. raffaele.dubbioso@unina.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Provitera</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Istituti Clinici Scientifici Maugeri IRCCS, Neurological Rehabilitation Unit of Telese Terme Institute, 82037, Telese Terme, Benevento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacella</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Public Health, University Federico II of Naples, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santoro</LastName><ForeName>Lucio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II of Naples, Via Sergio Pansini, 5, 80131, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manganelli</LastName><ForeName>Fiore</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II of Naples, Via Sergio Pansini, 5, 80131, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nolano</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II of Naples, Via Sergio Pansini, 5, 80131, Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Istituti Clinici Scientifici Maugeri IRCCS, Neurological Rehabilitation Unit of Telese Terme Institute, 82037, Telese Terme, Benevento, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054969" MajorTopicYN="Y">Primary Dysautonomias</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Autonomic dysfunction</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Non-motor symptoms</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Survival</Keyword></KeywordList><CoiStatement>The authors have no relevant financial or non-financial interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37358634</ArticleId><ArticleId IdType="pmc">PMC10511550</ArticleId><ArticleId IdType="doi">10.1007/s00415-023-11832-w</ArticleId><ArticleId IdType="pii">10.1007/s00415-023-11832-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mahoney CJ, Ahmed RM, Huynh W, et al. Pathophysiology and treatment of non-motor dysfunction in amyotrophic lateral sclerosis. CNS Drugs. 2021;35:483&#x2013;505. doi: 10.1007/s40263-021-00820-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-021-00820-1</ArticleId><ArticleId IdType="pubmed">33993457</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76:1263&#x2013;1269. doi: 10.1212/WNL.0b013e318214359f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318214359f</ArticleId><ArticleId IdType="pubmed">21464431</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen C, Caga J, Mahoney CJ, et al. Behavioural changes predict poorer survival in amyotrophic lateral sclerosis. Brain Cogn. 2021;150:105710. doi: 10.1016/j.bandc.2021.105710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bandc.2021.105710</ArticleId><ArticleId IdType="pubmed">33725515</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccione EA, Sletten DM, Staff NP, Low PA. Autonomic system and amyotrophic lateral sclerosis. Muscle Nerve. 2015;51:676&#x2013;679. doi: 10.1002/mus.24457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24457</ArticleId><ArticleId IdType="pmc">PMC4362936</ArticleId><ArticleId IdType="pubmed">25211238</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho MLL, Motta R, Battaglia MA, Brichetto G. Urinary disorders in amyotrophic lateral sclerosis subjects. Amyotroph Lateral Scler. 2011;12:352&#x2013;355. doi: 10.3109/17482968.2011.574141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.574141</ArticleId><ArticleId IdType="pubmed">21506896</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlandis S, V&#xe1;zquez-Costa JF, Mart&#xed;nez-Cuenca E, et al. Urodynamic findings in amyotrophic lateral sclerosis patients with lower urinary tract symptoms: results from a pilot study. Neurourol Urodyn. 2017;36:626&#x2013;631. doi: 10.1002/nau.22976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nau.22976</ArticleId><ArticleId IdType="pubmed">26895486</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfc;bling GS, Mie E, Bauer RM, et al. Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:174&#x2013;179. doi: 10.3109/21678421.2013.868001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.868001</ArticleId><ArticleId IdType="pubmed">24479577</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolano M, Provitera V, Manganelli F, et al. Non-motor involvement in amyotrophic lateral sclerosis: new insight from nerve and vessel analysis in skin biopsy. Neuropathol Appl Neurobiol. 2017;43:119&#x2013;132. doi: 10.1111/nan.12332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12332</ArticleId><ArticleId IdType="pubmed">27288647</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisano F, Miscio G, Mazzuero G, et al. Decreased heart rate variability in amyotrophic lateral sclerosis. Muscle Nerve. 1995;18:1225&#x2013;1231. doi: 10.1002/mus.880181103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880181103</ArticleId><ArticleId IdType="pubmed">7565918</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltadzhieva R, Gurevich T, Korczyn AD. Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2005;18:487&#x2013;493. doi: 10.1097/01.wco.0000183114.76056.0e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wco.0000183114.76056.0e</ArticleId><ArticleId IdType="pubmed">16155429</ArticleId></ArticleIdList></Reference><Reference><Citation>Low PA, Reich SG, Jankovic J, et al. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol. 2015;14:710&#x2013;719. doi: 10.1016/S1474-4422(15)00058-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00058-7</ArticleId><ArticleId IdType="pmc">PMC4472464</ArticleId><ArticleId IdType="pubmed">26025783</ArticleId></ArticleIdList></Reference><Reference><Citation>De Pablo-Fernandez E, Tur C, Revesz T, et al. Association of autonomic dysfunction with disease progression and survival in Parkinson disease. JAMA Neurol. 2017;74:970&#x2013;976. doi: 10.1001/jamaneurol.2017.1125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.1125</ArticleId><ArticleId IdType="pmc">PMC5710320</ArticleId><ArticleId IdType="pubmed">28655059</ArticleId></ArticleIdList></Reference><Reference><Citation>Stubendorff K, Aarsland D, Minthon L, Londos E. The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson&#x2019;s disease with dementia. PLoS&#xa0;One. 2012;7:3&#x2013;8. doi: 10.1371/journal.pone.0045451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045451</ArticleId><ArticleId IdType="pmc">PMC3462171</ArticleId><ArticleId IdType="pubmed">23049679</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira MCB, Ling H, Lees AJ, et al. Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 2019;90:555&#x2013;561. doi: 10.1136/jnnp-2018-319374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319374</ArticleId><ArticleId IdType="pubmed">30598430</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. 2017;5:1&#x2013;17. doi: 10.3389/fpubh.2017.00258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2017.00258</ArticleId><ArticleId IdType="pmc">PMC5624990</ArticleId><ArticleId IdType="pubmed">29034226</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry. 2006;77:390&#x2013;392. doi: 10.1136/jnnp.2005.072660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.072660</ArticleId><ArticleId IdType="pmc">PMC2077717</ArticleId><ArticleId IdType="pubmed">16484652</ArticleId></ArticleIdList></Reference><Reference><Citation>Labra J, Menon P, Byth K, et al. Rate of disease progression: a prognostic biomarker in ALS. J Neurol Neurosurg Psychiatry. 2016;87:628&#x2013;632. doi: 10.1136/jnnp-2015-310998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310998</ArticleId><ArticleId IdType="pubmed">26152368</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya K, Park SB, Geevasinga N, et al. Motor cortical function determines prognosis in sporadic ALS. Neurology. 2016;87:513&#x2013;520. doi: 10.1212/WNL.0000000000002912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002912</ArticleId><ArticleId IdType="pubmed">27402895</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, Rojas-Garcia R, Scott KM, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847&#x2013;852. doi: 10.1093/brain/awr351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr351</ArticleId><ArticleId IdType="pmc">PMC3286327</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis&#x2014;frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153&#x2013;174. doi: 10.1080/21678421.2016.1267768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Manera U, Calvo A, Daviddi M, et al. Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2019 doi: 10.1136/jnnp-2019-321153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-321153</ArticleId><ArticleId IdType="pubmed">31871138</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubbioso R, Spisto M, Hausdorff JM, Aceto G, Iuzzolino VV, Senerchia G, De Marco G, Marcuccio L, Femiano C, Iodice R, Salvatore E, Santangelo G, Trojano L, Moretta P. Cognitive impairment is associated with gait variability and fall risk in Amyotrophic Lateral Sclerosis. Eur J Neurol. 2023 doi: 10.1111/ene.15936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15936</ArticleId><ArticleId IdType="pubmed">37335396</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretta P, Spisto M, Ausiello FP, et al. Alteration of interoceptive sensitivity: expanding the spectrum of behavioural disorders in amyotrophic lateral sclerosis. Neurol Sci. 2022;43:5403&#x2013;5410. doi: 10.1007/s10072-022-06231-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06231-4</ArticleId><ArticleId IdType="pmc">PMC9385786</ArticleId><ArticleId IdType="pubmed">35751711</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lucia N, Ausiello FP, Spisto M, et al. The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness. Neurol Sci. 2020;41:2339&#x2013;2341. doi: 10.1007/s10072-020-04592-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04592-2</ArticleId><ArticleId IdType="pmc">PMC7359442</ArticleId><ArticleId IdType="pubmed">32666406</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser M, Marinus J, Stiggelbout AM, van Hilten JJ. Assessment of autonomic dysfunction in Parkinson&#x2019;s disease: the SCOPA-AUT. Mov Disord. 2004;19:306&#x2013;312. doi: 10.1002/mds.20153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.20153</ArticleId><ArticleId IdType="pubmed">15390007</ArticleId></ArticleIdList></Reference><Reference><Citation>Damon-Perri&#xe8;re N, Foubert-Samier A, De Cock VC, et al. Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time. Parkinsonism Relat Disord. 2012;18:612&#x2013;615. doi: 10.1016/j.parkreldis.2011.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2011.12.009</ArticleId><ArticleId IdType="pubmed">22236582</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubbioso R, Provitera V, Vitale F, et al. Cutaneous sensory and autonomic denervation in progressive supranuclear palsy. Neuropathol Appl Neurobiol. 2021 doi: 10.1111/nan.12692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12692</ArticleId><ArticleId IdType="pubmed">33421177</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy PGE, Duchen LW. A quantitative study of intermediolateral column cells in motor neuron disease and the Shy&#x2013;Drager syndrome. J Neurol Neurosurg Psychiatry. 1985;48:1103&#x2013;1106. doi: 10.1136/jnnp.48.11.1103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.48.11.1103</ArticleId><ArticleId IdType="pmc">PMC1028568</ArticleId><ArticleId IdType="pubmed">4078575</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H, Oyanagi K, Ikuta F. The intermediolateral nucleus in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 1993;86:190&#x2013;192. doi: 10.1007/BF00334889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00334889</ArticleId><ArticleId IdType="pubmed">8213074</ArticleId></ArticleIdList></Reference><Reference><Citation>Konno H, Yamamoto T, Iwasaki Y, Iizuka H. Shy-Drager syndrome and amyotrophic lateral sclerosis. Cytoarchitectonic and morphometric studies of sacral autonomic neurons. J Neurol Sci. 1986;73:193&#x2013;204. doi: 10.1016/0022-510X(86)90130-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(86)90130-9</ArticleId><ArticleId IdType="pubmed">3701375</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis J, Katona I, M&#xfc;ller-Newen G, et al. Small-fiber neuropathy in patients with ALS. Neurology. 2011;76:2024&#x2013;2029. doi: 10.1212/WNL.0b013e31821e553a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821e553a</ArticleId><ArticleId IdType="pubmed">21646630</ArticleId></ArticleIdList></Reference><Reference><Citation>Truini A, Biasiotta A, Onesti E, et al. Small-fibre neuropathy related to bulbar and spinal-onset in patients with ALS. J Neurol. 2015;262:1014&#x2013;1018. doi: 10.1007/s00415-015-7672-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7672-0</ArticleId><ArticleId IdType="pubmed">25683764</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla Bella E, Lombardi R, Porretta-Serapiglia C, et al. Amyotrophic lateral sclerosis causes small fiber pathology. Eur J Neurol. 2016;23:416&#x2013;420. doi: 10.1111/ene.12936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12936</ArticleId><ArticleId IdType="pubmed">26806218</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson DW, Biaggioni I, Burnstock G, et al. Primer on the autonomic nervous system. Elsevier; 2012.</Citation></Reference><Reference><Citation>Shimizu T, Kawata A, Kato S, et al. Autonomic failure in ALS with a novel SOD1 gene mutation. Neurology. 2000;54:1534&#x2013;1537. doi: 10.1212/WNL.54.7.1534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.54.7.1534</ArticleId><ArticleId IdType="pubmed">10751275</ArticleId></ArticleIdList></Reference><Reference><Citation>Parra-Cantu C, Zaldivar-Ruenes A, Martinez-Vazquez M, Martinez HR. Prevalence of gastrointestinal symptoms, severity of dysphagia, and their correlation with severity of amyotrophic lateral sclerosis in a Mexican cohort. Neurodegener Dis. 2021;21:42&#x2013;47. doi: 10.1159/000517613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000517613</ArticleId><ArticleId IdType="pubmed">34139704</ArticleId></ArticleIdList></Reference><Reference><Citation>Toepfer M, Folwaczny C, Lochm&#xfc;ller H, et al. Noninvasive 13C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis. Digestion. 1999;60:567&#x2013;571. doi: 10.1159/000007708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000007708</ArticleId><ArticleId IdType="pubmed">10545728</ArticleId></ArticleIdList></Reference><Reference><Citation>Toepfer M, Schroeder M, Klause R, et al. Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers. Eur J Med Res. 1997;2:473&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">9385117</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;zquez-Costa JF, Arlandis S, Hervas D, et al. Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder. J Neurol Sci. 2017;378:130&#x2013;136. doi: 10.1016/j.jns.2017.04.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.04.053</ArticleId><ArticleId IdType="pubmed">28566149</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan HAJ. Changes in shapes of surviving motor neurons in amyotrophic lateral sclerosis. Brain. 1993;116:203&#x2013;215. doi: 10.1093/brain/116.1.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/116.1.203</ArticleId><ArticleId IdType="pubmed">8453457</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlovic S, Stevic Z, Milovanovic B, et al. Impairment of cardiac autonomic control in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:272&#x2013;276. doi: 10.3109/17482960903390855.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903390855</ArticleId><ArticleId IdType="pubmed">20001491</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla Vecchia L, De Maria B, Marinou K, et al. Cardiovascular neural regulation is impaired in amyotrophic lateral sclerosis patients. A study by spectral and complexity analysis of cardiovascular oscillations. Physiol Meas. 2015;36:659&#x2013;670. doi: 10.1088/0967-3334/36/4/659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/0967-3334/36/4/659</ArticleId><ArticleId IdType="pubmed">25798998</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maria B, Bari V, Marchi A, et al (2015) Cardiovascular control indexes in amyotrophic lateral sclerosis patients and their relation with clinical markers. Proceedings of the annual international conference of the IEEE engineering in medicine and biology society, EMBS 2015-November:2055&#x2013;2058. 10.1109/EMBC.2015.7318791</Citation><ArticleIdList><ArticleId IdType="pubmed">26736691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipp A, Tank J, Stoffels M, et al. Riluzole and blood pressure in multiple system atrophy. Clin Auton Res. 2003;13:271&#x2013;274. doi: 10.1007/s10286-003-0100-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-003-0100-z</ArticleId><ArticleId IdType="pubmed">12955551</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>